Infection of mice, ferrets, and rhesus macaques with a clinical mumps virus isolate

Journal of Virology

Volumn 87, Issue 14, 2013, Pages 8158-8168

  Xu, Pei ^a,b   Huang, Zhixiang ^c   Gao, Xiudan ^a   Michel, Frank J ^a   Hirsch, Gwen ^a   Hogan, Robert J ^a   Sakamoto, Kaori ^a   Ho, Wenzhe ^d   Wu, Jianguo ^d   He, Biao ^a,d  

^a UNIVERSITY OF GEORGIA   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c WUHAN UNIVERSITY   (China)

^d WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VIRUS ANTIGEN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EPIDEMIC; FEMALE; FERRET; GENETIC VARIABILITY; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MUMPS; MUMPS VIRUS; NONHUMAN; PAROTID GLAND DISEASE; PAROTID GLAND SWELLING; PRIORITY JOURNAL; RHESUS MONKEY; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS SHEDDING; VIRUS STRAIN; WEIGHT CHANGE;

ANIMALS; CERCOPITHECUS AETHIOPS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FERRETS; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; MICE; MICE, INBRED BALB C; MUMPS; MUMPS VIRUS; NEUTRALIZATION TESTS; PAROTID GLAND; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY; VERO CELLS;

EID: 84880323433     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01028-13     Document Type: Article

References (35)

1. Galazka AM, Robertson SE, Kraigher A. 1999. Mumps and mumps vaccine: a global review. Bull. World Health Organ. 77:3-14.
2. Bjorvatn B, Wolontis S. 1973. Mumps meningoencephalitis in Stockholm, November 1964-July 1971. I. Analysis of a hospitalized study group. Questions of selection and representativity. Scand. J. Infect. Dis. 5:253-260.
3. Afzal MA, Buchanan J, Heath AB, Minor PD. 1997. Clustering of mumps virus isolates by SH gene sequence only partially reflects geographical origin. Arch. Virol. 142:227-238.
4. Amexis G, Rubin S, Chatterjee N, Carbone K, Chumakov K. 2003. Identification of a new genotype H wild-type mumps virus strain and its molecular relatedness to other virulent and attenuated strains. J. Med. Virol. 70:284-286.
5. Inou Y, Nakayama T, Yoshida N, Uejima H, Yuri K, Kamada M, Kumagai T, Sakiyama H, Miyata A, Ochiai H, Ihara T, Okafuji T, Okafuji T, Nagai T, Suzuki E, Shimomura K, Ito Y, Miyazaki C. 2004. Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes. J. Med. Virol. 73:97-104.
6. Orvell C, Kalantari M, Johansson B. 1997. Characterization of five conserved genotypes of the mumps virus small hydrophobic (SH) protein gene. J. Gen. Virol. 78(Part 1):91-95.
7. Santos CL, Ishida MA, Foster PG, Sallum MA, Benega MA, Borges DB, Correa KO, Constantino CR, Afzal MA, Paiva TM. 2008. Detection of a new mumps virus genotype during parotitis epidemic of 2006-2007 in the state of Sao Paulo, Brazil. J. Med. Virol. 80:323-329.
8. Wu L, Bai Z, Li Y, Rima BK, Afzal MA. 1998. Wild type mumps viruses circulating in China establish a new genotype. Vaccine 16:281-285.
9. Yeo RP, Afzal MA, Forsey T, Rima BK. 1993. Identification of a new mumps virus lineage by nucleotide sequence analysis of the SH gene of ten different strains. Arch. Virol. 128:371-377.
10. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. 2008. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa, 2006. Vaccine 26:3601-3607.
11. Centers for Disease Control and Prevention. 2009. Mumps outbreak - New York, New Jersey, Quebec, 2009. MMWR Morb. Mortal. Wkly Rep. 58:1270-1274.
12. Cusi MG, Correale P, Valassina M, Sabatino M, Valensin PE, Donati M, Gluck R. 2001. Comparative study of the immune response in mice immunized with four live attenuated strains of mumps virus by intranasal or intramuscular route. Arch. Virol. 146:1241-1248.
13. Tsurudome M, Yamada A, Hishiyama M, Ito Y. 1987. Replication of mumps virus in mouse: transient replication in lung and potential of systemic infection. Arch. Virol. 97:167-179.
14. Vandermeulen C, Verhoye L, Vaidya S, Clement F, Brown KE, Hoppenbrouwers K, Leroux-Roels G. 2010. Detection of mumps virusspecific memory B cells by transfer of peripheral blood mononuclear cells into immune-deficient mice. Immunology 131:33-39.
15. Gordon I, Pavri K, Cohen SM. 1956. Response of ferrets to mumps virus. J. Immunol. 76:328-333.
16. Flanagan TD, Andrada JA, Barron AL, Witebsky E. 1971. Response to experimental infection with mumps virus in rhesus monkeys. Infect. Immun. 3:642-647.
17. Johnson CD, Goodpasture EW. 1934. An investigation of the etiology of mumps. J. Exp. Med. 59:1-19.
18. Genco RJ, Emmings FG, Flanagan TD. 1972. Immunocyte response to experimental mumps virus infection in rhesus monkeys. Fed Proc. 31: A760.
19. Findlay GM, Clarke LP. 1934. The experimental production of mumps in monkeys. Br. J. Exp. Pathol. 15:309-313.
20. Buynak EB, Hilleman MR. 1966. Live attenuated mumps virus vaccine. 1. Vaccine development. Proc. Soc. Exp. Biol. Med. 123:768-775.
21. Levenbuk IS, Nikolayeva MA, Chigirinsky AE, Ralf NM, Kozlov VG, Vardanyan NV, Sliopushkina VG, Kolomiets OL, Rukhamina ML, Grigoryeva LV. 1979. On the morphological evaluation of the neurovirulence safety of attenuated mumps virus strains in monkeys. J. Biol. Stand. 7:9-19.
22. Rozina EE, Hilgenfeldt M. 1985. Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys. Acta Virol. 29:225-230.
23. Rubin SA, Snoy PJ, Wright KE, Brown EG, Reeve P, Beeler JA, Carbone KM. 1999. The mumps virus neurovirulence safety test in rhesus monkeys: a comparison of mumps virus strains. J. Infect. Dis. 180:521-525.
24. Yuzepchuk SA, Rozina EE, Kaptsova TI, Kulish EA. 1975. Morphological differences in the central nervous system and organs of monkeys inoculated intracerebrally with virulent and attenuated strains of mumps virus. Acta Virol. 19:305-310.
25. St. Geme JW, Jr, Peralta H, Van Pelt LF. 1972. Intrauterine infection of the rhesus monkey with mumps virus: abbreviated viral replication in the immature fetus as an explanation for split immunologic recognition after birth. J. Infect. Dis. 126:249-256.
26. Kristensson K, Orvell C, Malm G, Norrby E. 1984. Mumps virus infection of the developing mouse brain-appearance of structural virus proteins demonstrated with monoclonal antibodies. J. Neuropathol. Exp. Neurol. 43:131-140.
27. McCarthy M, Jubelt B, Fay DB, Johnson RT. 1980. Comparative studies of five strains of mumps virus in vitro and in neonatal hamsters: evaluation of growth, cytopathogenicity, and neurovirulence. J. Med. Virol. 5:1-15.
28. Wolinsky JS, Stroop WG. 1978. Virulence and persistence of three prototype strains of mumps virus in newborn hamsters. Arch. Virol. 57:355-359.
29. Wolinsky JS, Klassen T, Baringer JR. 1976. Persistence of neuroadapted mumps virus in brains of newborn hamsters after intraperitoneal inoculation. J. Infect. Dis. 133:260-267.
30. Xu P, Li Z, Sun D, Lin Y, Wu J, Rota PA, He B. 2011. Rescue of wild-type mumps virus from a strain associated with recent outbreaks helps to define the role of the SH ORF in the pathogenesis of mumps virus. Virology 417:126-136.
31. Xu P, Luthra P, Li Z, Fuentes S, D'Andrea JA, Wu J, Rubin S, Rota PA, He B. 2012. The V protein of mumps virus plays a critical role in pathogenesis. J. Virol. 86:1768-1776.
32. Standardization Administration of China (SAC). 2011. Laboratory animal--- microbiological standards and monitoring. GB 14922.2-2011. Standardization Administration of China (SAC), Beijing, People's Republic of China.
33. Gordon JE, Kilham L. 1949. Ten years in the epidemiology of mumps. Am. J. Med. Sci. 218:338-359.
34. Hviid A, Rubin S, Muhlemann K. 2008. Mumps. Lancet 371:932-944.
35. Enders JF, Kane LW, Cohen S, Levens JH. 1945. Immunity in mumps. I. Experiments with monkeys (Macacus mulatta). The development of complement-fixing antibody following infection and experiments on immunization by means of inactivated virus and convalescent human serum. J. Exp. Med. 81:93-117.